Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
Rang în acțiuni
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Preț acțiune
$3.89
Capitalizare de piață
$3.30B
Schimbare (1 zi)
-3.14%
Schimbare (1 an)
43.11%
Țară
CN
Tranzacționează Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Categorie
Healthcare
Venituri pentru Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Venituri în Jun 2026 TTM: $332.95M
Conform celor mai recente rapoarte financiare ale Guangdong Zhongsheng Pharmaceutical Co., Ltd., venitul actual al companiei (TTM) este $332.95M. În anul 2024, compania a avut un venit de $338.04M o scădere comparativ cu venitul din anul 2023, care a fost de $368.79M. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru Guangdong Zhongsheng Pharmaceutical Co., Ltd. din 2006 până în 2026
Venituri la sfârșitul fiecărui an
| An | Venituri | Schimbă |
|---|---|---|
| 2026 (TTM) | $332.95M | -7.66% |
| 2025 | $360.58M | 6.67% |
| 2024 | $338.04M | -8.34% |
| 2023 | $368.79M | -4.94% |
| 2022 | $387.97M | 1.51% |
| 2021 | $382.18M | 31.69% |
| 2020 | $290.21M | -20.17% |
| 2019 | $363.55M | 5.90% |
| 2018 | $343.31M | 13.72% |
| 2017 | $301.90M | 23.85% |
| 2016 | $243.77M | 0.33% |
| 2015 | $242.96M | 15.01% |
| 2014 | $211.26M | 17.56% |
| 2013 | $179.70M | 26.42% |
| 2012 | $142.15M | 19.38% |
| 2011 | $119.07M | 22.66% |
| 2010 | $97.07M | 20.15% |
| 2009 | $80.79M | 13.84% |
| 2008 | $70.98M | 28.15% |
| 2007 | $55.38M | 32.26% |
| 2006 | $41.88M | 0.00% |
Venituri pentru companii similare sau concurente
| Companie | Venituri | Diferență de venituri | Țara |
|---|---|---|---|
| $23.54B | 6,968.81% |
DE
|
|
| $23.73B | 7,028.77% |
DE
|
|
| $29.24B | 8,682.09% |
JP
|
|
| $5.85B | 1,656.66% |
CH
|
|
| $6.34B | 1,804.89% |
IN
|
